| Eileen M Alexy, PHD,RN, APNC | |
|
2000 Pennington Rd, Ewing, NJ 08628 | |
| (609) 771-2490 | |
| (609) 637-5159 |
| Full Name | Eileen M Alexy |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist |
| Location | 2000 Pennington Rd, Ewing, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669646154 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | NJ0008100 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Eileen M Alexy, PHD,RN, APNC 2000 Pennington Rd, Ewing, NJ 08628 Ph: (609) 771-2490 | Eileen M Alexy, PHD,RN, APNC 2000 Pennington Rd, Ewing, NJ 08628 Ph: (609) 771-2490 |
News Archive
Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of healthcare supplies, announced today the signing of a cost management prime vendor agreement with Bloomington Hospital in Bloomington, Ind. The five-year agreement is anticipated to save the hospital an estimated $2 million over the term of the contract.
Classic psychedelics, such as LSD, psilocybin mushrooms and mescaline, previously have been shown to occasion lasting improvements in mental health. But researchers led by University of Alabama at Birmingham School of Public Health investigators wanted to advance the existing research and determine whether classic psychedelics might be protective with regard to suicidal thoughts.
German researchers have identified four biomarkers that correctly determine malignancy of urinary bladder cancers and contribute to the accurate prediction of patient outcomes. Their results are published in the September issue of The Journal of Molecular Diagnostics.
Childhood abuse is more common in women with migraine who suffer depression than in women with migraine alone, according to a study published in the September 4, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
Pfizer and Protalix (NYSE-Amex: PLX) today announced that they have entered into an agreement to develop and commercialize taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) in development for the potential treatment of Gaucher's disease.
› Verified 7 days ago
Kelly Cantisano, Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 830 Bear Tavern Rd, Medop Behavioral Health Associates Of Nj Pc, Ewing, NJ 08628 Phone: 973-800-2655 |